Literature DB >> 1900406

Antiendothelial cell antibodies detected by a cellular based ELISA in Kawasaki disease.

E J Tizard1, E Baguley, G R Hughes, M J Dillon.   

Abstract

Kawasaki disease is an acute vasculitic illness of childhood associated with significant morbidity and mortality. A cellular based enzyme linked immunosorbent assay (ELISA) was used to demonstrate the presence of antiendothelial cell antibodies in sera from children with Kawasaki disease. Twenty one of 32 patients with Kawasaki disease had raised IgM antibody titres and four had raised IgG antiendothelial antibody titres. There was a significant difference in the IgM antiendothelial cell antibody titres when comparing the patients with normals and febrile controls. The antibody titre paralleled the disease activity in patients studied serially. There was no relative increase in binding of antiendothelial cell antibodies after cytokine stimulation. These findings may be of importance in further research into the understanding of mechanisms involved in this and other forms of vasculitis in man.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1900406      PMCID: PMC1792841          DOI: 10.1136/adc.66.2.189

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  12 in total

1.  The treatment of Kawasaki syndrome with intravenous gamma globulin.

Authors:  J W Newburger; M Takahashi; J C Burns; A S Beiser; K J Chung; C E Duffy; M P Glode; W H Mason; V Reddy; S P Sanders
Journal:  N Engl J Med       Date:  1986-08-07       Impact factor: 91.245

2.  Kawasaki disease: cardiac problems and management.

Authors:  H Kato; O Inoue; T Akagi
Journal:  Pediatr Rev       Date:  1988-01

3.  Immunoregulatory abnormalities in mucocutaneous lymph node syndrome.

Authors:  D Y Leung; R L Siegel; S Grady; A Krensky; R Meade; E L Reinherz; R S Geha
Journal:  Clin Immunol Immunopathol       Date:  1982-04

4.  [Acute febrile mucocutaneous syndrome with lymphoid involvement with specific desquamation of the fingers and toes in children].

Authors:  T Kawasaki
Journal:  Arerugi       Date:  1967-03

5.  Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria.

Authors:  E A Jaffe; R L Nachman; C G Becker; C R Minick
Journal:  J Clin Invest       Date:  1973-11       Impact factor: 14.808

Review 6.  Kawasaki syndrome.

Authors:  A H Rowley; F Gonzalez-Crussi; S T Shulman
Journal:  Rev Infect Dis       Date:  1988 Jan-Feb

7.  Nationwide survey on Kawasaki disease in Japan.

Authors:  H Yanagawa; T Kawasaki; I Shigematsu
Journal:  Pediatrics       Date:  1987-07       Impact factor: 7.124

8.  Polymerase activity in lymphocyte culture supernatants from patients with Kawasaki disease.

Authors:  J C Burns; R S Geha; E E Schneeberger; J W Newburger; F S Rosen; L S Glezen; A S Huang; J Natale; D Y Leung
Journal:  Nature       Date:  1986 Oct 30-Nov 5       Impact factor: 49.962

9.  Endothelial cell activation and high interleukin-1 secretion in the pathogenesis of acute Kawasaki disease.

Authors:  D Y Leung; R S Cotran; E Kurt-Jones; J C Burns; J W Newburger; J S Pober
Journal:  Lancet       Date:  1989-12-02       Impact factor: 79.321

10.  High-dose intravenous gammaglobulin for Kawasaki disease.

Authors:  K Furusho; T Kamiya; H Nakano; N Kiyosawa; K Shinomiya; T Hayashidera; T Tamura; O Hirose; Y Manabe; T Yokoyama
Journal:  Lancet       Date:  1984-11-10       Impact factor: 79.321

View more
  11 in total

Review 1.  Anti-neutrophil cytoplasmic antibodies and anti-endothelial cell antibodies.

Authors:  M J Dillon; E J Tizard
Journal:  Pediatr Nephrol       Date:  1991-03       Impact factor: 3.714

Review 2.  Kawasaki disease: recent advances.

Authors:  M Levin; E J Tizard; M J Dillon
Journal:  Arch Dis Child       Date:  1991-12       Impact factor: 3.791

3.  Study of the autoantibody profile after the acute phase of Kawasaki disease in a cohort of children from North India.

Authors:  R Venkatraman; S Singh; R W Minz
Journal:  Rheumatol Int       Date:  2005-11-25       Impact factor: 2.631

Review 4.  Intravenous immunoglobulin in neurological disease: a specialist review.

Authors:  C M Wiles; P Brown; H Chapel; R Guerrini; R A C Hughes; T D Martin; P McCrone; J Newsom-Davis; J Palace; J H Rees; M R Rose; N Scolding; A D B Webster
Journal:  J Neurol Neurosurg Psychiatry       Date:  2002-04       Impact factor: 10.154

Review 5.  Anti-endothelial cell antibodies and autoimmune diseases.

Authors:  N Del Papa; D Gambini; P L Meroni
Journal:  Clin Rev Allergy       Date:  1994

6.  Serum immunoglobulin G reactive with endothelial cells in inflammatory bowel disease.

Authors:  A M Sawyerr; B E Pottinger; C O Savage; N J Bradley; M Hudson; A J Wakefield; J D Pearson; R E Pounder
Journal:  Dig Dis Sci       Date:  1994-09       Impact factor: 3.199

7.  Noninvasive determination of endothelial cell function in the microcirculation in Kawasaki syndrome.

Authors:  Gregory H Kurio; Katrine A Zhiroff; Lily J Jih; Arnost S Fronek; Jane C Burns
Journal:  Pediatr Cardiol       Date:  2007-09-21       Impact factor: 1.655

8.  Sera from patients with systemic lupus erythematosus demonstrate enhanced IgG binding to endothelial cells pretreated with tumour necrosis factor alpha.

Authors:  N P Quadros; P J Roberts-Thomson; A S Gallus
Journal:  Rheumatol Int       Date:  1995       Impact factor: 2.631

9.  The level of IgA antibodies to human umbilical vein endothelial cells can be enhanced by TNF-alpha treatment in children with Henoch-Schönlein purpura.

Authors:  Y-H Yang; S J Wang; Y-H Chuang; Y-T Lin; B-L Chiang
Journal:  Clin Exp Immunol       Date:  2002-11       Impact factor: 4.330

10.  Antiendothelial cell antibodies can be cytotoxic to endothelial cells without cytokine pre-stimulation and correlate with ELISA antibody measurement in Kawasaki disease.

Authors:  K Kaneko; C O Savage; B E Pottinger; V Shah; J D Pearson; M J Dillon
Journal:  Clin Exp Immunol       Date:  1994-11       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.